
Zynex Inc
NASDAQ:ZYXI

Zynex Inc
Operating Income
Zynex Inc
Operating Income Peer Comparison





Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Zynex Inc
NASDAQ:ZYXI
|
Operating Income
$10.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
![]() |
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.9B
|
CAGR 3-Years
18%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
![]() |
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.7B
|
CAGR 3-Years
24%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
![]() |
Stryker Corp
NYSE:SYK
|
Operating Income
$4.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
![]() |
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
See Also
What is Zynex Inc's Operating Income?
Operating Income
10.5m
USD
Based on the financial report for Jun 30, 2024, Zynex Inc's Operating Income amounts to 10.5m USD.
What is Zynex Inc's Operating Income growth rate?
Operating Income CAGR 5Y
0%
Over the last year, the Operating Income growth was -46%. The average annual Operating Income growth rates for Zynex Inc have been 18% over the past three years .